Please sign in to follow a disease.

Anti-nmdar encephalitis

Clinical trials for Anti-nmdar encephalitis explained in plain language.

Never miss a new study

Get alerted when new Anti-nmdar encephalitis trials appear

Sign up with your email to follow new studies for Anti-nmdar encephalitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Completed 1

Blood-Filtering therapy may tame rare brain inflammation in children

Disease control Completed

This trial investigates whether a blood-filtering procedure called immunoadsorption (IA), combined with the drug rituximab, can improve neurological function in children aged 0-18 with severe anti-NMDAR encephalitis. Participants receive 10 IA sessions over 28 days plus weekly ri…

Matched conditions: ANTI-NMDAR ENCEPHALITIS

Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC

Anti-nmdar encephalitis

Get alerted when new Anti-nmdar encephalitis trials appear

Blood-Filtering therapy may tame rare brain inflammation in children